HIV/AIDS Treatment Guidelines Search Results| NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Resultados de la búsqueda 81 – 100 de 339

What to Start: Protease Inhibitor–Based Regimens

When Antiretroviral Therapy Is Being Taken When Pregnancy Occurs

What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal

Previous Experience With Antiretroviral Medications but Not Currently on Antiretroviral Therapy During Current Pregnancy

What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy

Lack of Viral Suppression While on Antiretroviral Therapy in Pregnancy

Table 6. What to Start: Initial Antiretroviral Regimens During Pregnancy

Table 7. Situation-Specific Recommendations for Use of Antiretroviral Drugs During Pregnancy and When Trying to Conceive

Antiretroviral Drug Regimens and Pregnancy Outcomes

Cystoisosporiasis (Formerly Isosporiasis)

Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV

Special Populations

Hepatitis B Virus/HIV Coinfection

Hepatitis C Virus/HIV Coinfection

HIV-2 and Pregnancy

Prenatal Care, Antiretroviral Therapy, and HIV Management When HIV Was Perinatally Acquired

Early (Acute and Recent) HIV Infection

Cytomegalovirus Disease